Healthtech Startups

ReviMo develops Niko, a mobility assistance device that helps individuals with limited mobility transfer, move, and elevate to a standing level, reducing dependence on caregivers. The device targets patients with limited mobility and their caregivers, and is subject to FDA approval.

1 investor

ReviMo develops Niko, a motorized mobility device that assists individuals with limited mobility in transfers and standing. The device is designed for personal use and rehabilitation, offering safety features and compatibility with standard furniture.

1 investor

Revinova provides a learning platform and AI agent embedded in clinical trial management systems (CTMS) to train sites for clinical trials and reduce protocol deviations. The platform transforms study documents into role-based training and offers real-time guidance to trial coordinators, investigators, and data managers within their existing CTMS workflows.

1 investor

Reviva Pharmaceuticals is a clinical-stage drug developer with a pipeline of two in-house-discovered new chemical entities, brilaroxazine (RP5063) and RP1208, developed using its chemical genomics platform. Its lead candidate, brilaroxazine, is being developed for schizophrenia and has completed a Phase 3 trial.

1 investor

RreviveMed applies artificial intelligence to metabolomics and biology to support drug discovery in the pharmaceutical and biotech sector.

1 investor

Reviving Mind provides a healthcare platform that connects individuals with healthcare professionals and leverages collaborative care models for mental health and wellness. The company serves patients seeking well-being support across various mental health and sleep disorders.

1 investor

Revolve develops a surgical robotics platform with 5mm wristed instruments and zero-footprint design for operating rooms, enabling digital surgery at costs comparable to laparoscopy. The system is designed for access across independent outpatient centers and large health networks.

1 investor

Revolver Therapeutics develops peptide therapeutics targeting transcription factors for cancer treatment. It uses a proprietary peptide discovery and screening platform to screen millions of peptides and identify functional inhibitors.

1 investor

Revuud operates an online marketplace that connects healthcare systems directly with skilled IT talent, allowing them to engage without a third-party staffing intermediary. It serves the healthcare industry in the United States.

1 investor

REWHITE is a verified beauty information platform that aggregates skincare, procedures, cosmetics, and wellness content in one place, combining expert insights with user experiences. It connects users with trusted dermatology and cosmetic clinics while providing personalized beauty solutions based on individual skin types and concerns.

1 investor

Rex Bionics develops REX, a hands-free robotic exoskeleton that allows people with severe neurological conditions and mobility impairments to stand, walk, and perform structured functional exercises under healthcare professional guidance. It serves patients with conditions such as spinal cord injury, multiple sclerosis, stroke, cerebral palsy, and acquired brain injury, as well as the physiotherapists delivering their rehabilitation therapy.

1 investor

Rexall is a pharmacy and drugstore chain offering prescriptions, health services, and everyday health and wellness products to consumers, both in-store and online with delivery through Instacart. It also provides tools for managing prescriptions and a points-based rewards program.

1 investor

VitalStrata provides AI software to help managed care organizations improve the accuracy of risk adjustment coding and documentation, making their operations more resistant to audit scrutiny.

1 investor

Wahoo Fitness offers cycling and fitness products that customers can purchase using pre-tax Health Savings Account (HSA) and Flexible Spending Account (FSA) funds through a partnership with Truemed. The company enables qualified health expenses to be paid with tax-advantaged accounts, potentially saving customers up to 30% through pre-tax purchasing power.

1 investor

Rhapsogen is developing a precision biologic therapy aimed at treating autoimmune diseases, focused on efficacy, safety, and durability.

1 investor

Rheo is developing an all-in-one device for continuous vitals-based patient monitoring, using algorithms and AI to predict patient outcomes and automate inpatient vital sign collection. It targets hospitals, serving doctors, nurses, administrators, and patients to improve care quality and reduce costs.

1 investor

Rheon Medical develops novel surgical devices to treat glaucoma, aiming to improve treatment efficacy and reduce post-operative complications for patients. The company is a spin-off from EPFL and combines engineering expertise with clinical guidance from ophthalmology specialists.

1 investor

RheumaFinder is an AI-powered application that analyzes CT images to detect structural bone lesions in the sacroiliac joints, intended to support radiologists in identifying patients with rheumatic disease. The software operates as a cloud-native add-on to existing PACS systems for opportunistic detection of joint damage in medical imaging studies.

1 investor

Rheyo manufactures a light-activated chairside whitening system for dental practices, distributed through a pilot program model where practices receive the device free and pay per-use for consumable kits.

1 investor

Rhizome AI provides an AI research platform that answers regulatory and clinical questions by citing documents from health authority databases across multiple markets, with built-in hallucination prevention. The product serves pharmaceutical companies, consultants, and researchers who need to understand regulatory positions and guidance from FDA, EMA, and other regional authorities.

1 investor

Rhodes Health is the practice of Orli Rhodes, a registered dietitian offering personalised diet and nutrition consultations for conditions such as diabetes, food intolerances, digestive and metabolic disorders, and weight management. It provides online and in-clinic one-on-one support plus nutrition talks and workshops for schools, corporate clients, and events, based in London.

1 investor

Rhovica Neuroimaging AG develops a patented navigation system for safe placement of brain catheters in acute cerebral hemorrhage cases, enabling real-time monitoring and bedside treatment in emergency settings. The company serves hospitals and emergency care providers in the medical device and neurosurgery sector.

1 investor

Rhythmlink designs and manufactures medical devices and provides contract manufacturing services for neurodiagnostic equipment, serving healthcare providers and diagnostic centers. The company specializes in physical connections between patients and neurophysiologic recording equipment.

1 investor

Rhythmm handles healthcare pre-authorization requests by combining AI-powered workflows with human specialists to accelerate insurance approvals and reduce denials for hospitals, clinics, and insurance networks.

1 investor